MI
PRCT icon

Motiv8 Investments’s Procept Biorobotics PRCT Stock Holding History

Motiv8 Investments’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1K Buy
+21
New +$696 ﹤0.01% 858

Other funds holding PRCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Motiv8 Investments's PRCT Position: Q4 2025 in Review

Motiv8 Investments opened a new position in Procept Biorobotics (PRCT) in Q4 2025: 21 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #858 among its holdings.

263 funds tracked by Wall St. Rank hold PRCT as of Q4 2025.

  • Motiv8 Investments held 21 shares of Procept Biorobotics worth $1K as of Q4 2025.
  • Procept Biorobotics was a new Motiv8 Investments position in Q4 2025.
  • Procept Biorobotics made up ﹤0.01% of Motiv8 Investments's portfolio in Q4 2025, its #858 holding.
  • 263 funds tracked by Wall St. Rank held Procept Biorobotics as of Q4 2025.

Based on Motiv8 Investments's 13F filing for Q4 2025, filed 13 Feb 2026.